BofA analyst Geoff Meacham talks about downgrading Pfizer, upgrading Merck, and what he thinks will become the best selling medicine of all time.

Learn more about your ad choices. Visit megaphone.fm/adchoices

The First $100 Billion Drug

Get the lowdown on high finance each week with Barron’s columnist Jack Hough. Business leaders and trendspotters, insights and absurdities—this is Wall Street like you've never heard before.

Business

Investing

Careers

Management & Marketing

Business News

Shopping

Plus, the charms of CLOs. BofA’s Jared Woodard sizes up income strategies.

Learn more about your ad choices. Visit megaphone.fm/adchoices

The Problem With Covered Call Writing

Plus, Tesla earnings, European stock picks, and jellied eels.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Fuzzy Panda Attacks Globe Life

In this non-episode, Jack and Jackson touch on dual-class stocks, the Paramount deal, fixed income, and cabbage.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Supervoting Shares and Bond Barbells

Why Calvin Klein maker PVH got the worst of an apparel stock drop.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Underpants Armageddon

Jack talks with Barron’s senior writer Al Root about the slowdown in EV growth and the takeoff in hybrids.

Learn more about your ad choices. Visit megaphone.fm/adchoices

The First $100 Billion Drug

Download our free app to listen on your phone